Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1140-1148

  Zhang, Jianying ^a   Ren, Song ^a   Sun, Dongfeng ^a   Shen, Garry X ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aminoguanidine; Endothelial cells; Glycated LDL; Plasminogen activator inhibitor 1; Tissue plasminogen activator

Indexed keywords

ALKADIENE; AMINOGUANIDINE; LOW DENSITY LIPOPROTEIN; LYSINE DERIVATIVE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; SORBITOL; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; FIBRINOLYSIS; GLYCATION; HUMAN; HUMAN CELL; LIPID METABOLISM; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031926661     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1140     Document Type: Article

References (15)

1. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992;6:2905-2914.
2. Garcia-Frade LJ, de la Calle H, Torrado MC, Lara JI, Cuellar L, Garcia-Avello A. Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus. Thromb Res. 1990;59:51-59.
3. Henkin JH, Marcotte P, Yang H. The plasminogen-plasmin system. Prog Cardiovasc Dis. 1991;34:179-192.
4. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol. 1988;4:93-126.
5. Loskutoff DJ, Aken BEV, Seiffert D. Abnormalities in the fibrinolytic system of the vascular wall associated with atherosclerosis. Ann N Y Acad Sci. 1994;748:177-184.
6. Schneiderman J, Sawdey MS, Keeton MR, Bordin CM, Bernstein EF, Dilley RB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A. 1992;89:6998-7002.
7. Carmassi F, Morale M, Paccent R, DeNegre F, Monzani F, Navalesi R, Mariani G. Coagulation and fibrinolytic system impairment in insulin dependent diabetic mellitus. Thromb Res. 1992;67:643-654.
8. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990; 10:1067-1073.
9. Tremoli E, Camera M, Maderna P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: an LDL receptor-independent phenomenon. Arterioscler Thromb. 1993;13:338-346.
10. Latron Y, Chautan M, Anfosso F, Alessi MC, Nalbpne G, Lafont H, Juhan-Vague I. Stimulating effect of oxidized low density lipoprotein on plasminogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler Thromb. 1991;11:1821-1829.
11. Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H, Horiguchi M, Yasue H. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue type plasminogen activator release from endothelial cells. Circ Res. 1993:73:335-343.
12. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. J Biol Chem. 1991:226:2459-2465.
13. Ren S, Man RYK, Angel A, Shen GX. Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Atherosclerosis. 1997; 128:1-10.
14. Levin EG, Miles LA, Fless GM, Scanu AM, Baynham P, Curtiss LK, Plow EF. Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. Arterioscler Thromb. 1994;14: 438-442.
15. Kobayashi K, Watanabe J, Umeda F, Nawata H. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocrinol J. 1995; 42:461-465.